Valuation: IDEXX Laboratories, Inc.

Market Cap 40.99B 36.62B 34.13B 30.94B 58.23B 3,891B 58.69B 409B 160B 2,024B 154B 151B 6,493B P/E 2026 *
35.2x
P/E 2027 * 31.2x
Enterprise Value 41.36B 36.95B 34.44B 31.22B 58.76B 3,926B 59.22B 413B 161B 2,042B 155B 152B 6,552B EV / Sales 2026 *
8.76x
EV / Sales 2027 * 7.96x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day-0.69%
1 week+0.95%
Current month-0.36%
1 month+3.09%
3 months-7.78%
6 months-9.35%
Current year-23.09%
1 week 506.12
Extreme 506.12
528.48
1 month 501.17
Extreme 501.17
536.84
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 102.45
Extreme 102.45
769.98
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Exercice

Director

6,609 0.0084%
8/20/26 Exercice

Chief Financial Officer

616 0.0008%
7/30/26 Free

Director

49 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%+0.95%-17.84%+22.09% 41.28B
+0.78%+4.53%-21.90%+12.92% 176B
+1.17%+6.80%-2.69%+29.25% 118B
-0.02%+1.56%-22.57%+9.57% 108B
-0.31%-0.27%-46.72%-10.85% 75.34B
+1.55%+4.34%+4.14%+74.68% 62.03B
-0.06%+0.66%+19.28%+66.34% 52.8B
-0.80%+3.92%+0.38%-27.57% 51.45B
-0.17%+0.42% - - 31.37B
-1.00%+2.00%+30.46%+11.64% 32.42B
Average +0.04%+2.68%-6.39%+20.90% 74.89B
Weighted average by Cap. +0.31%+3.28%-11.98%+19.43%

Financials

2026 *2027 *
Net sales 4.72B 4.22B 3.93B 3.56B 6.71B 448B 6.76B 47.1B 18.44B 233B 17.73B 17.34B 748B 5.14B 4.59B 4.28B 3.88B 7.3B 488B 7.36B 51.26B 20.07B 254B 19.3B 18.88B 814B
Net income 1.18B 1.05B 981M 889M 1.67B 112B 1.69B 11.75B 4.6B 58.17B 4.43B 4.33B 187B 1.31B 1.17B 1.09B 991M 1.87B 125B 1.88B 13.1B 5.13B 64.82B 4.93B 4.82B 208B
Net Debt 368M 329M 306M 278M 523M 34.93B 527M 3.67B 1.44B 18.17B 1.38B 1.35B 58.29B -97.34M -86.95M -81.05M -73.48M -138M -9.24B -139M -971M -380M -4.81B -366M -358M -15.42B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
26-10-13 US$520.31 -0.69% 445,410
26-10-12 US$523.94 +1.15% 552,787
26-10-09 US$518.00 +0.95% 466,778
26-10-08 US$513.14 +1.28% 696,677
26-10-07 US$506.67 -1.70% 716,449
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
520.31USD
Average target price
701.33USD
Spread / Average Target
+34.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. IDXX Stock